MedPath

Does triage of chest X-rays with artificial intelligence shorten the time to lung cancer diagnosis: a randomised controlled trial

Not Applicable
Conditions
ung cancer
Cancer
Registration Number
ISRCTN78987039
Lead Sponsor
ottingham University Hospitals NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
150000
Inclusion Criteria

1. Chest X-ray referred from primary care
2. Age = 18 years
3. Anteroposterior (AP) or Posteroanterior (PA) view

Exclusion Criteria

1. Age <18 years
2. CXR referral not from primary care
3. Lateral X-ray view of the chest

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Time from chest X-ray to lung cancer diagnosis in days from the cancer waiting time database<br>2. Time from chest X-ray to CT (when performed) in days from the radiology information system
Secondary Outcome Measures
NameTimeMethod
1. Time to first respiratory cancer outpatient appointment in days from the cancer waiting time database<br>2. Time to treatment start for lung cancer patients in days from the cancer waiting time database<br>3. Agreement between AI (qXR) and human readers for normal/abnormal interpretation of chest X-ray as an agree/disagree decision with discordance review by a thoracic radiologist where required<br>4. Number of urgent lung cancer referrals from the cancer waiting time database<br>5. The incidence of lung cancer from the cancer waiting time database<br>6. The stage of lung cancer diagnosis from the cancer waiting time database<br>7. Cost-effectiveness of AI support at the time of CXR acquisition and prioritisation for immediate review of CXRs; to be measured by difference in costs per patient diagnosed, per percentage increase in early-stage diagnosis and potentially per QALY subject to the availability of health utilities in the published studies
© Copyright 2025. All Rights Reserved by MedPath